Overall, these data show that FGF9 acts as a potent growth factor for hepatoma/hepatocarcinoma cells and appears to enhance the cells ́ ability for clone formation, migration and disintegration of blood/lymphatic endothelia. This evidence concerns the gene FGF9 and hepatocellular carcinoma.